Skip to main content
Erschienen in: BMC Infectious Diseases 1/2024

Open Access 01.12.2024 | Research

Association of haemato-biochemical indices and blood composite ratios with microfilaridermia in Onchocerciasis patients

verfasst von: Linda Batsa Debrah, Charles Gyasi, Monica Ahiadorme, Abu Abudu Rahamani, Vera Serwaa Opoku, Prince Obeng, Jubin Osei-Mensah, Michael Agyemang Obeng, Derrick Adu Mensah, Alexander Yaw Debrah

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2024

Abstract

Background

Onchocerciasis causes chronic systemic inflammation. Several studies have used markers such as haemato-biochemical indices to predict the occurrence of systemic inflammation. This study assessed the variability and predictability of haemato-biochemical indices and blood composite ratios (BCRs) in microfilariae positive (MF+) and microfilariae negative (MF-) subgroups of onchocercomata participants.

Methods

One hundred and five (105) MF + and 34 MF- participants were retrospectively recruited into the study. Screening for the presence of O. volvulus microfilariae was done from skin snips taken from the left and right iliac crests of participants using established and approved protocols. Haematological and biochemical indices were measured using standard laboratory automated analyzers. Blood composite ratios (BCRs) were calculated as ratios of the absolute parameters involved.

Results

A significantly increased total WBC, absolute eosinophil, eosinophil percent and absolute basophil were observed in the MF + participants compared to MF- participants. Reduced gamma-glutamyl transferase (GGT) with increased estimated glomerular filtration rate (eGFR) was significantly associated with MF + participants compared to MF- participants. BCRs were significantly higher for eosinophil-to-neutrophil ratio (ENR), eosinophil-to-monocyte ratio (EMR), eosinophil-to-basophil ratio (EBR) and eosinophil-to-lymphocyte ratio (ELR) in MF + participants compared to MF- participants. After multivariate adjustment, onchocercomata participants with increased eosinophil counts (aOR = 13.86, 95% CI [2.07–92.90], p = 0.007), ENR x10 (aOR = 1.42, 95% CI [1.05–1.93], p = 0.025), EMR (aOR = 2.64, 95% CI [1.25–5.60], p = 0.011), EBR (aOR = 1.07, 95% CI [1.01–1.10], p = 0.020) and ELR x10 (aOR = 1.69, 95% CI [1.14–2.51], p = 0.009) were more likely to have microfilaridermia.

Conclusions

Elevated eosinophil counts with higher ENR, EMR, EBR and ELR levels are significantly associated with microfilaridermia in onchocercomata participants. Combining BCRs with eosinophil count significantly led to an improvement in the conventional model for predicting microfilaridermia.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12879-024-09278-0.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Onchocerciasis, a chronic helminth infection, is one of the leading causes of morbidity and mortality worldwide [1, 2]. The infection is caused by a filarial nematode Onchocerca volvulus and transmitted by blackfly vectors [3]. In humans, onchocerciasis can lead to severe dermal and ocular pathologies often as a result of an acute inflammatory response to dead microfilariae (MF) [4]. Community-directed treatment with ivermectin (CDTI) remains the World Health Organization (WHO) strategy for achieving high therapeutic coverage, and elimination of the infection with a global target of 12 (31%) endemic countries verified for having interrupted transmission by 2030 [5]. CDTI approach has improved treatment coverage and subsequently broke transmission cycles― radically altering the consequences of O. volvulus infection [6, 7]. However, recent reports show that CDTI alone is unlikely to eliminate onchocerciasis in areas where fear of ivermectin (IVM) adverse events and death are detrimentally anchored in the population [1, 8]. Alternative strategies are therefore needed for onchocerciasis elimination [8, 9], and research on diagnostic factors in this group is of special interest.
The clinical spectrum of human onchocerciasis manifests as two polar forms among infected participants who reside in areas that have undergone none or only a few rounds of mass drug administration (MDA) [10]. The hyporesponsive form, characterized by participants with palpable onchocercomas (nodules) but no strong pathology amidst high MF skin loads, is more common than the hyperresponsive form [10] which manifests as sowda with few or no skin MF. In addition to these clinical manifestations, a subgroup of the hyporesponsive form has been reported in hyperendemic areas that have undergone multiple rounds of ivermectin (IVM) [11, 12]. This subgroup, believed to stem from the effects of repeated preventive chemotherapy with IVM, has palpable nodules with adult worms but are a-microfilaridermic and manifest little or no dermal/skin and ocular pathology(-ies) [13]. To date, there remains a clinical dearth of understanding between this population of a-microfilaridermic (MF-) and hyporesponsive forms (MF+).
A strong inflammatory response through the activation of inflammatory cells is characteristic of helminth infection [14]. Onchocerciasis is known to activate both the innate and adaptive immune system cells in the host [15, 16]. O. volvulus infection is characterized by type 2 immune response with changes in lymphocytes, eosinophils, basophils, neutrophils and mast cell distributions [17]. Several studies have shown that the vast majority of incoming L3 are killed by innate immune cells [14, 17, 18]. Also, evidence from other reports shows that granulocytes are key mediators of microfilariae killing following antihelminthic treatment [13, 14].
High neutrophil levels after multiple rounds of MDA have been implicated in a-microfilaridermias [13, 19]. The neutrophils in these participants correlated negatively with eosinophils [13]. Also, high eosinophil levels with low neutrophil and basophil levels have been implicated in MF + participants [13, 20]. Thus, suggesting a potential interaction among granulocytes in onchocerciasis infection. Further to this, without concomitant neutrophil involvement, high eosinophil counts alone may not predict distinction among onchocercomata participants with or without skin MF [16, 19].
Blood composite ratios (BCRs) of inflammatory cells are novel and stable biomarkers of vast clinical relevance in inflammatory diseases, mortality and prognosis [2123]. A growing number of studies suggest that BCRs may serve as an independent discriminatory predictor of chronic diseases [2426]. Thus, BCRs such as eosinophil-to-neutrophil ratio (ENR), eosinophil-to-basophil ratio (EBR), eosinophil-to-monocyte ratio (EMR), neutrophil-to-lymphocyte ratio (NLR) and eosinophil-to-lymphocyte ratio (ELR) may be stable biomarkers in onchocerciasis disease. However, the variability and predictability of these ratios have not been previously elucidated in MF + and MF- onchocerciasis participants. To resolve this, we examined the haemato-biochemical profile and selected BCRs among MF + and MF- participants in the Sefwi Akontombra district of Ghana.

Materials and methods

Ethical consideration

Ethical approval of the study was obtained from the Committee on Human Research Publication and Ethics (CHRPE) of the School of Medicine and Dentistry of the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. Community leaders were consulted at the beginning of the study for their support and permission, and written approval was sought from the Western North Regional and the Sefwi Akontombra District Health Directorates. Informed consent was obtained from all participants and/or their legal guardians either by thumb printing or signing. This study was part of other larger studies titled: “The efficacy of rifampicin 35 mg/kg/d plus albendazole 400 mg/d given for 7 or 14 days against onchocerciasis– a randomized, controlled, parallel-group, open-label, phase II pilot trial” with registration number PACTR202009704006025, and “Prevalence assessment for onchocerciasis in some selected districts in Ghana”. The ethical approvals received for these studies were CHRPE/AP/359/20 and CHRPE/AP/492/20.

Study population

A total of 139 participants, made up of 105 MF + and 34 MF- participants (males and females) aged between 18 to 68 years were retrospectively recruited from November 2020 to April 2021. Recruitment of the O. volvulus infected participants was done from 25 communities located adjacent to and along the Tano river in the Sefwi Akontombra district of Ghana. The Sefwi Akontombra district lies between latitudes 6o N and 6o 30’ N and longitudes 2o 45’ W and 2o 15’ W in the north-eastern part of the Western North Region [27]. It is characterized by moderate to heavy rainfall of between 1,524 mm and 1,780 mm per annum, with the peak in September-October. The communities within the districts are intersected by the Tano River and other major tributaries like Suhein, Kunuma, Sui, and the Yoyo [27]. Agricultural activities primarily along the Tano river play a major role in the district’s economy through the production of cocoa, palm trees, and other food crops [27].

Data collection

Demographic characteristics, clinical data, IVM intake status and laboratory findings for each participant were extracted from electronic records (REDCap). Electronic data were doubled entered by two independent data entry persons and were validated with original paper case report forms (pCRF). Participants were assured of the safety and confidentiality of their responses and laboratory data. Participants with a history of chronic diseases, haematological disorders, pregnancy, non-steroidal anti-inflammatory drug (NSAID) usage, recent antimalarial drug intake, incomplete or no laboratory results, intestinal helminths and other parasites, history of smoking and alcoholism were excluded from the study. Figure 1. shows the participant enrollment flowchart of the study. Participants were classified as MF + and MF- as previously reported [13, 20].

MDA rounds/intake assessment

MDA has been implemented by the Ministry of Health in Ghana through the district’s disease control office for over 20 years in the district with considerable compliance. Therefore, at the time of sampling, most of the participants self-reported having taken part in the MDA programme from the district. The self-reported intake and participation in MDA programmes were used to assess individual IVM intake for each participant. To prevent MDA intake/treatment rounds recall bias, responses from participants were re-checked/cross-checked from the treatment records with the community health volunteers in the communities who had the MDA records for every household. This was done before the numbers were used in any analyses.

Distance to the nearest river

Distances to the nearest river were measured using eTrex 10 (Garmin International, Inc., USA). Briefly, the coordinates of the communities were acquired using the GPS function of the eTrex 10 and referenced to the nearest river around the communities. The distance from a focal point in the community to the nearest river was then measured and recorded in kilometres (km).

Parasitological and laboratory assessment

Participants with O. volvulus infection who had at least one palpable nodule were recruited for the study [28]. Screening for the presence of skin microfilariae (MF/mg of skin) was done as previously reported [13]. Infection with Plasmodium parasite(s), intestinal helminths and other parasites (protozoans and flagellates) ― were diagnosed using standard laboratory methods. Venous blood was collected by venipuncture from the median cubital superficial vein of the upper limb by sterile disposable hypodermic vacutainer needles into tubes with ethylenediaminetetraacetic acid (EDTA) as an anticoagulant (for haematological analytes) and gel clot activators (for biochemistry analytes). Haematological indices were then measured using a standard laboratory automated analyzer (Sysmex XN 350, USA). Serum alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transferase (GGT) and creatinine were measured using an automated biochemical analyzer (Selectra ProS ELITech Clinical Chemistry, Germany) according to the manufacturer’s instructions. The calculation of eGFR was based on the formulae proposed by Levey et al. [29]. Blood Composite ratios were calculated as a ratio of the absolute parameters involved. Early morning stool samples from participants were collected and analyzed using wet mount and Kato-Katz techniques. In the Kato-Katz method, counting and recording of stool parasites were carried out according to the manufacturer’s instructions by experienced laboratory scientists.

Statistical analysis

Statistical analysis was done using GraphPad Prism version 8.4.3 (GraphPad Software, Inc., San Diego, CA) and SPSS Statistics 25.0 software (SPSS Inc., Chicago, IL, USA). Continuous variables were expressed as median and interquartile ranges whereas categorical variables were expressed as frequencies and percentages. Comparisons between continuous variables were done using the Mann-Whitney U-test. The chi-square test and Fisher’s exact tests were performed for categorical variables where appropriate. The receiver operating characteristics (ROC) curve analyses were done to assess the predictability of microfilaridermia by the BCRs. Test for multicollinearity were conducted to identify and address high correlations between predictor variables, enhance model stability and improve interpretability. Predictors with Variable Inflation Factor (VIF) greater than 10 were excluded from further analysis. Univariate and multivariate logistic regression analyses were done to determine the association between BCRs and demographic characteristics. Furthermore, C-statistics were done to assess the incremental predictability of blood cell ratios. To optimize BCRs for clinical practice, their cut-off values with their specificity, sensitivity, negative predictive values (NPV) and positive predictive values (PPV) were assessed. Statistical significance was set at p < 0.05.

Results

Baseline characteristics of study participants

Among all enrolled onchocercomata participants, 105 were microfilaria-positive (MF+) and 34 were microfilaria-negative (MF-). MF + participants were younger, having a higher proportion of males and farmers than MF- participants (Table 1). The median years lived in endemic area for MF + participants were significantly lower (25.0 [15.0–30.0] vs. 30.0 [22.0–35.0], p = 0.007) than MF- participants (Table 1). A higher percentage of the MF- participants lived 1–2 km from the nearest river (58.8% vs. 38.1%, p = 0.046) compared to MF + participants (Table 1). Participants who lived < 1 km (4.0 [4.0–5.0]) from the nearest river had significantly taken higher rounds of MDA compared to those who either lived 1–2 km (4.0 [3.0–4.0]) or > 2 km (3.0 [2.0–4.8]) from the nearest river (Fig. 2).
A p-value less than 0.05 was considered statistically significant. ns; not significant, km; kilometre. Distance to the nearest river was measured as a community reference point to the nearest river using eTrex10 (Garmin International, Inc., USA).
Table 1
Baseline socio-demographic characteristics of study participants
Variable
N
a-Microfilaridermic (n = 34)
N
Microfilaridermic (n = 105)
p-value
Age (years)
34
41.5 [34.5–45.0]
105
37.0 [30.0–44.0]
0.070¥
Year in an endemic area (years)
34
30.0 [22.0–35.0]
105
25.0 [15.0–30.0]
0.007¥
Gender (male, n.%)
34
22 [64.7]
105
70 [66.7]
0.834a
Distance to the nearest river (n.%)
     
< 1.00 km
34
12 [35.3]
105
43 [41.0]
0.046a
1.00–2.00 km
 
20 [58.8]
 
40 [38.1]
 
> 2.00 km
 
2 [5.9]
 
22 [21.0]
 
Occupation
34
 
105
 
0.001b
 Farmer
 
23 [67.7]
 
89 [84.8]
 
 Trader
 
8 [23.5]
 
3 [2.8]
 
 Others
 
3 [8.8]
 
13 [12.4]
 
Has taken IVM before, n (%)
34
34 [100.0]
105
95 [90.5]
0.062b
Individual IVM intake
34
4.0 [3.75–5.0]
105
4.0 [3.0–5.0]
0.056¥
total nodule sites
34
1.0 [1.0–2.0]
105
2.0 [1.0–2.0]
0.089¥
total nodule counts
34
1.0 [1.0–2.3]
105
2.0 [1.0–3.0]
0.169¥
Mf skin load (Mf/mg)
34
0.00 [0.00–0.00]
105
0.62 [0.25–2.00]
< 0.001¥
a: chi-square test;b: Fishers’ exact test;¥: Mann-Whitney U-test analysis; km: kilometres; Mf/mg: microfilariae per milligram of skin weight

MF + participants exhibit disproportionate abnormalities in haematological and biochemical indices

Table 2 shows the abnormalities in haematological and biochemical indices of MF + and MF- participants based on reference ranges set by the manufacturers of the analyzers. MF + participants showed disproportionate abnormalities in haematological indices for RBC (6.7%), absolute eosinophil (51.4%), eosinophil percent (58.1%), absolute lymphocyte (6.7%), lymphocyte percent (18.1%), absolute monocyte (9.5%), monocyte percent (5.7%) and basophil percent (2.9%). Biochemical indices such as ALT (5.7%), AST (9.5%), GGT (7.6%), creatinine (2.9%) and eGFR (37.1%) were also disproportionately abnormal in MF + participants. Disproportionate abnormalities in RBC (8.8%), absolute eosinophil (14.7%), eosinophil percent (29.4%), absolute lymphocyte (2.9%), lymphocyte percent (26.5%), monocyte percent (2.9%), ALT (11.8%), AST (5.9%), GGT (11.8%), creatinine (8.8%) and eGFR (50.0%) were also observed in MF- participants.
Table 2
Haematological and biochemical ranges and abnormalities of study participants
Variable
unit
Classification
a-Microfilaridermics (MF-, n = 34)
Microfilaridermics (MF+, n = 105)
Total n (%)
Reference range
RBC
x106/L
Normal
31 (91.2)
98 (93.3)
129 (92.8)
2.50–5.50
Abnormal
3 (8.8)
7 (6.7)
10 (7.2)
HGB
g/dL
Normal
34 (100.0)
105 (100.0)
139 (100.0)
8.0–17.0
Abnormal
0 (0.0)
0 (0.0)
0 (0.0)
HCT
%
Normal
34 (100.0)
105 (100.0)
139 (100.0)
26.0–50.0
Abnormal
0 (0.0)
0 (0.0)
0 (0.0)
PLT
x103/L
Normal
33 (97.1)
104 (99.0)
137 (98.6)
50–400
Abnormal
1 (2.9)
1 (1.0)
2 (1.4)
Total WBC
x109/L
Normal
34 (100.0)
104 (99.0)
138 (99.3)
3.00–15.00
Abnormal
0 (0.0)
1 (1.0)
1 (0.7)
Neutrophil Abs
x109/L
Normal
34 (100.0)
104 (99.0)
138 (99.3)
1.50–7.00
Abnormal
0 (0.0)
1 (1.0)
1 (0.7)
Lymphocyte Abs
x109/L
Normal
33 (97.1)
98 (93.3)
131 (94.2)
1.00–3.70
Abnormal
1 (2.9)
7 (6.7)
8 (5.8)
Monocyte Abs
x109/L
Normal
34 (100.0)
95 (90.5)
129 (92.8)
0.00–0.70
Abnormal
0 (0.0)
10 (9.5)
10 (7.2)
Eosinophil Abs
x109/L
Normal
29 (85.3)
51 (48.6)
80 (57.6)
0.00–0.40
Abnormal
5 (14.7)
54 (51.4)
59 (42.4)
Basophil Abs
x109/L
Normal
34 (100.0)
105 (100.0)
139 (100.0)
0.00–0.10
Abnormal
0 (0.0)
0 (0.0)
0 (0.0)
Neutrophil %
%
Normal
34 (100.0)
104 (99.0)
138 (99.3)
37.0–72.0
Abnormal
0 (0.0)
1 (1.0)
1 (0.7)
Lymphocyte %
%
Normal
25 (73.5)
86 (81.9)
111 (79.9)
20.0–50.0
Abnormal
9 (26.5)
19 (18.1)
28 (20.1)
Monocyte %
%
Normal
33 (97.1)
99 (94.3)
132 (95.0)
0.0–14.0
Abnormal
1 (2.9)
6 (5.7)
7 (5.0)
Eosinophil %
%
Normal
24 (70.6)
44 (41.9)
68 (48.9)
0.0 − 6.0
Abnormal
10 (29.4)
61 (58.1)
71 (51.1)
Basophil %
%
Normal
34 (100.0)
102 (97.1)
136 (97.8)
0.0–1.0
Abnormal
0 (0.0)
3 (2.9)
3 (2.2)
ALT
U/L
Normal
30 (88.2)
99 (94.3)
129 (92.8)
0.0–40.0
Abnormal
4 (11.8)
6 (5.7)
10 (7.2)
AST
U/L
Normal
32 (94.1)
95 (90.5)
127 (91.4)
0.0–40.0
Abnormal
2 (5.9)
10 (9.5)
12 (8.6)
GGT
U/L
Normal
30 (88.2)
97 (92.4)
127 (91.4)
0.0–55.0
Abnormal
4 (11.8)
8 (7.6)
12 (8.6)
Creatinine
µmol/L
Normal
31 (91.2)
102 (97.1)
133 (95.7)
53.0–124.0
Abnormal
3 (8.8)
3 (2.9)
6 (4.3)
eGFR
mL/min/1.73m2
Normal
17 (50.0)
66 (62.9)
83 (59.7)
> 90.00
Abnormal
17 (50.0)
39 (37.1)
56 (40.3)
RBC; red blood cell count, HGB; haemoglobin concentration, PLT; platelet count, WBC; white blood cell count, ALT; alanine transaminase, AST; aspartate transaminase, GGT; gamma-glutamyl transferase, eGFR; estimated glomerular filtration rate

MF + participants show significant variabilities in haematological and biochemical indices

MF + participants had significantly higher Total WBC (5.39 [4.78–6.60] vs. 4.71 [3.97–5.50], p = 0.001), absolute eosinophil (0.42 [0.19–0.84] vs. 0.14 [0.08–0.36], p < 0.0001), absolute basophil (0.03 [0.02–0.04] vs. 0.02 [0.01–0.03], p = 0.001) and eosinophil percent (8.0 [3.8–14.1] vs. 3.2 [1.9–7.5], p < 0.0001) with reduced GGT (25.3 [20.1–32.8] vs. 33.4 [21.9–39.6], p = 0.013) compared to MF- participants (Table 3). Strikingly, MF- participants had significantly lower eGFR levels (89.7 [82.8–94.8] vs. 94.8 [84.4–107.5], p = 0.040) compared to MF + participants (Table 3). However, RBC, HGB, PLT, absolute neutrophil, absolute lymphocyte, absolute monocyte, neutrophil percent, lymphocyte percent, basophil percent, monocyte percent, ALT, AST, and creatinine did not differ significantly (p > 0.05) between MF + and MF- participants (Table 3).
Table 3
Biochemical and Haematological Variabilities among Study Participants
Variable
unit
N
a-Microfilaridermic (n = 34)
N
Microfilaridermic (n = 105)
p-value
median (IQR)
median (IQR)
RBC
x109/L
34
4.73 [4.24–5.24]
105
4.57 [4.20–4.95]
0.209
HGB
g/dL
34
13.5 [12.1–14.6]
105
13.1 [12.1–14.2]
0.390
HCT
%
34
41.2 [38.2–43.6]
105
40.1 [37.1–42.8]
0.253
PLT
x109/L
34
196 [123–246]
105
200 [161–247]
0.343
Total WBC
x109/L
34
4.71 [3.97–5.50]
105
5.39 [4.78–6.60]
0.001
Neutrophil Abs
x109/L
34
1.78 [1.54–2.54]
105
1.99 [1.46–2.69]
0.602
Lymphocyte Abs
x109/L
34
2.07 [1.79–2.44]
105
2.28 [1.85–2.85]
0.069
Monocyte Abs
x109/L
34
0.43 [0.32–0.53]
105
0.47 [0.35–0.59]
0.110
Eosinophil Abs
x109/L
34
0.14 [0.08–0.36]
105
0.42 [0.19–0.84]
< 0.0001
Basophil Abs
x109/L
34
0.02 [0.01–0.03]
105
0.03 [0.02–0.04]
0.001
Neutrophil %
%
34
40.4 [35.6–48.4]
105
37 [31.2–44.7]
0.055
Lymphocyte %
%
34
44.9 [38.9–53.6]
105
42.2 [36.3–49.0]
0.198
Monocyte %
%
34
9.0 [7.7–9.8]
105
8.0 [6.5–10.5]
0.216
Eosinophil %
%
34
3.2 [1.9–7.5]
105
8.0 [3.8–14.1]
< 0.0001
Basophil %
%
34
0.4 [0.3–0.6]
105
0.5 [0.4–0.7]
0.057
ALT
U/L
34
24.0 [20.1–29.6]
105
22.4 [17.5–30.2]
0.513
AST
U/L
34
22.3 [18.5–29.0]
105
23.0 [17.8–28.5]
0.745
GGT
U/L
34
33.4 [21.9–39.6]
105
25.3 [20.1–32.8]
0.013
Creatinine
µmol/L
34
95.0 [79.0–103.0]
105
91.0 [79.5–101.0]
0.289
eGFR
mL/min/1.73m2
34
89.7 [82.8–94.8]
105
94.8 [84.4–107.5]
0.040
RBC = red blood cell; HGB = haemoglobin concentration; HCT = haematocrit; PLT = platelet; WBC = white blood cell; abs = absolute; ALT = alanine transaminase; AST = aspartate transaminase; GGT = gamma-glutamyl transferase; eGFR = estimated glomerular filtration; IQR = inter-quartile range. Mann-Whitney U-test was used for all analyses. p-value < 0.05 was considered statistically significant

Increased blood composite ratios are significantly associated with MF + participants

Blood composite ratios (BCR) were significantly higher for ENR x10 (2.30 [0.87–4.14] vs. 0.73 [0.40–1.81], p < 0.0001), EMR (0.90 [0.43–1.84] vs. 0.36 [0.22–0.57], p < 0.0001), EBR (14.67 [7.38–24.07] vs. 8.20 [5.25–12.00], p = 0.0006) and ELR x10 (1.76 [0.87– 3.55] vs. 0.72 [0.40–1.70], p = 0.0001) in MF + participants compared to MF- participants (Fig. 3). Although MF + participants showed a lower NLR (0.88 [0.64–1.14] vs. 0.92 [0.69–1.29]) compared to MF- participants, no statistically significant difference was observed (p = 0.361) (Fig. 3).

BCRs correlate positively with eosinophil but negatively with neutrophil levels in MF + participants

Among the MF- participants, ENR x10, EMR, EBR and ELR x10 showed a significant positive correlation with absolute eosinophil and eosinophil percent (Fig. 4A). ENR x10, EMR, ELR x10 and not EBR showed a significant positive correlation with absolute basophil and basophil percent (Fig. 4A). ENR showed a significant negative correlation with neutrophil percent whiles ELR x10 showed a negative correlation with lymphocyte percent (Fig. 4A). ENR and ELR showed a significant positive correlation with creatinine (Fig. 4A). The numerical outcome of Spearman’s correlation analysis can be found in the supplementary sheet as supporting information.
Among the MF + participants, ENR x10, EMR, EBR and ELR x10 showed a significant positive correlation with absolute eosinophil and eosinophil percent but a negative correlation with absolute neutrophil and neutrophil percent (Fig. 4B). ENR x10, EMR and ELR x10 showed a significant positive correlation with absolute basophil and basophil percent (Fig. 4B). EMR showed a significant negative correlation with absolute monocyte and monocyte percent whiles ELR x10 showed a negative correlation with lymphocyte percent (Fig. 4B). Both absolute eosinophil and eosinophil percent showed a significant negative correlation with absolute neutrophil and neutrophil percent (Fig. 4B). Absolute eosinophil and eosinophil percent showed a significant positive correlation with absolute basophil and basophil percent (Fig. 4B). The numerical outcome of Spearman’s correlation analysis can be found in the supplementary sheet as supporting information.

BCRs show fair predictability in classifying MF + and a-MF participants

Receiver operator characteristic (ROC) curve analysis were performed to determine the diagnostic ability of BCRs in classifying MF + participants and MF- participants (Fig. 5). The analysis showed that ENR x10 (AUC = 72.5%; p < 0.001), EMR (AUC = 73.0%; p < 0.001) and ELR x10 (AUC = 71.8%; p < 0.001) had a fair predictive value in classifying MF + and MF- participants. Absolute eosinophil (AUC = 73.8%; p < 0.001) had the highest predictive values in discriminating onchocerciasis patients with microfilaridermia and a-microfilaridermia than either of the blood composite ratios (Fig. 5). EBR and basophil had the lowest predictive values of 69.3% and 67.4% respectively. For optimal cutoff values of BCRs that best distinguished between MF + and MF-, an ENR x10 > 2.265, EBR > 14.25, and absolute eosinophil > 0.415 showed higher specificity but lower sensitivity (Table 4). The optimal cutoff values of EMR that best distinguished between MF + and MF- were values > 0.395 with 79.1% sensitivity and 61.8% specificity (Table 4). ELR x10 cutoff value > 1.160 showed 63.8% sensitivity and 70.6% specificity in predicting onchocerciasis patients with microfilaridermia (Table 4).
Table 4
Cutoff values of blood composite ratios in predicting microfilaridermia
Parameter
Cut-off
Sensitivity (95% CI)
Specificity (95% CI)
Accuracy (95% CI)
PPV (95% CI)
NPV (95% CI)
p-Value
Eosinophil [Abs]
> 0.415
50.5 [40.6–60.4]
88.2 [72.6–96.7]
59.7 [51.1–67.9]
93.0 [83.8–97.1]
36.6 [31.5–42.0]
< 0.001
Basophil [Abs]
> 0.025
63.8 [53.9–73.0]
67.7 [49.5–82.6]
64.8 [56.2–72.7]
85.9 [78.6–91.0]
37.7 [30.0–46.1]
0.001
ENR x10
> 2.265
50.5 [40.6–60.4]
91.2 [76.3–98.1]
60.4 [51.8–68.6]
94.6 [85.5–98.2]
37.4 [32.4–42.6]
< 0.001
EMR
> 0.395
79.1 [70.0–86.4]
61.8 [43.6–77.8]
74.8 [66.8–81.8]
86.5 [80.5–90.8]
48.8 [37.7–60.1]
< 0.001
EBR
> 14.25
51.4 [41.5–61.3]
85.3 [68.9–95.1]
59.7 [51.1–67.9]
91.5 [82.5–96.1]
36.3 [30.9–42.0]
< 0.001
ELR x10
> 1.160
63.8 [53.9–73.0]
70.6 [52.5–84.9]
65.5 [56.9–73.3]
87.0 [79.6–92.0]
38.5 [31.1–46.9]
< 0.001
PPV; positive predictive value, NPV; negative predictive value, CI; confidence interval, abs; absolute count, EBR: eosinophil-to-basophil ratio; EMR: eosinophil-to-monocyte ratio; NLR: neutrophil-to-lymphocyte ratio; ELR: eosinophil-to-lymphocyte ratio. The Chi-square test was used for all analyses. p-value less than 0.05 was considered statistically significant

Eosinophil count and BCRs are independently associated with increased odds of microfilaridermia in Onchocerciasis

Univariate analysis showed that ENR x10 (cOR = 1.60, 95% CI [1.18–2.19, p = 0.003), EMR (cOR = 3.68, 95% CI [1.64–8.26], p = 0.002), EBR (cOR = 1.09, 95% CI [1.03–1.15], p = 0.003) and ELR x10 (cOR = 1.93, 95% CI [1.29–2.88], p = 0.001) were significantly associated with increased odds of microfilariae positivity (Table 5). After adjusting for age, gender, years lived in endemic area, distance to the nearest river, occupation, individual IVM intake, total nodule counts, total nodule sites, ENR x10 (aOR = 1.42, 95% CI [1.05–1.93], p = 0.025), EMR (aOR = 2.64, 95% CI [1.25–5.60], p = 0.011), EBR (aOR = 1.07, 95% CI [1.01–1.10], p = 0.020) and ELR x10 (aOR = 1.69, 95% CI [1.14–2.51], p = 0.009) were independently associated with increased odds of microfilariae positivity (Table 6). High eosinophil counts were independently associated with microfilariae positivity (aOR = 13.86, 95% CI [2.07–92.90], p = 0.007) (Table 6).
Table 5
Univariate logistics regression analysis for microfilaridermia among study participants
Variable
Univariate analysis
OR (95 CI %)
p-value
Age (years)
0.97 [0.93–1.01]
0.121
Year in an endemic area (years)
0.96 [0.92–0.99]
0.011
gender (male)
1.09 [0.48–2.46]
0.834
Distance to the river (< 1 km)
0.33 [0.07–1.59]
0.165
Distance to the river (1–2 km)
0.18 [0.04–0.85]
0.030
Occupation (Farmer)
2.66 [1.09–6.51]
0.032
Individual IVM intake
0.79 [0.61–1.02]
0.080
Total nodule sites
1.54 [0.89–2.66]
0.124
Total nodule counts
1.11 [0.85–1.45]
0.425
Total WBC
1.74 [1.20–2.51]
0.003
Basophil
1.65 [1.16–2.34]
0.005
Eosinophil
28.18 [3.97–200.13]
0.001
GGT
0.98 [0.96–1.00]
0.067
eGFR
1.02 [1.00–1.05]
0.062
ENR x10
1.60 [1.18–2.19]
0.003
EMR
3.68 [1.64–8.26]
0.002
EBR
1.09 [1.03–1.15]
0.003
ELR x10
1.93 [1.29–2.88]
0.001
WBC; white blood cell count, GGT; gamma glutamyl transferase; ENR; eosinophil-to-neutrophil ratio, EMR; eosinophil-to-monocyte ratio, EBR; eosinophil-to-basophil ratio, ELR; eosinophil-to-lymphocyte ratio
Table 6
Multivariate logistics regression analysis for microfilaridermia among study participants
Variable
Multivariate analysis
Model 1 + ENR
Model 1 + EMR
Model 1 + EBR
aOR (95 CI %)
p-value
aOR (95 CI %)
p-value
aOR (95 CI %)
p-value
Age (years)
0.99 [0.93–1.05]
0.687
0.99 [0.93–1.05]
0.676
0.99 [0.93–1.05]
0.688
gender (male)
0.61 [0.20–1.80]
0.367
0.65 [0.22–1.92]
0.438
0.60 [0.20–1.80]
0.361
Year in an endemic area (years)
0.97 [0.92–1.01]
0.162
0.97 [0.92–1.02]
0.174
0.96 [0.92–1.01]
0.105
Distance to the river (< 1 km)
0.29 [0.05–1.68]
0.167
0.26 [0.04–1.50]
0.130
0.31 [0.05–1.76]
0.185
Distance to the river (1–2 km)
0.18 [0.03–1.02]
0.052
0.15 [0.03–0.84]
0.031
0.17 [0.03–0.97]
0.046
Occupation (Farmer)
5.67 [1.58–20.33]
0.008
4.97 [1.41–17.56]
0.013
6.01 [1.67–21.59]
0.006
Individual IVM intake
0.90 [0.65–1.25]
0.526
0.92 [0.51–1.49]
0.563
0.92 [0.66–1.28]
0.619
Total nodule counts
0.94 [0.58–1.52]
0.791
0.92 [0.57–1.49]
0.745
0.91 [0.56–1.46]
0.687
Total nodule sites
1.52 [0.57–4.08]
0.408
1.48 [0.55–4.02]
0.441
1.48 [0.55–3.99]
0.436
ENR x10
1.42 [1.05–1.93]
0.025
    
EBR
  
2.64 [1.25–5.60]
0.011
  
EMR x10
    
1.07 [1.01–1.10]
0.020
 
Multivariate analysis
 
Model 1 + ELR
Model 1 + Eosinophil
  
 
aOR (95 CI %)
p-value
aOR (95 CI %)
p-value
  
Age (years)
0.99 [0.93–1.06]
0.654
0.99 [0.93–1.05]
0.696
  
gender (male)
0.56 [0.19–1.69]
0.304
0.55 [0.18–1.71]
0.300
  
Year in an endemic area (years)
0.97 [0.92–1.02]
0.177
0.97 [0.92–1.02]
0.196
  
Distance to the river (< 1 km)
0.28 [0.05–1.66]
0.163
0.25 [0.04–1.50]
0.126
  
Distance to the river (1–2 km)
0.16 [0.03–0.91]
0.039
0.16 [0.03–0.93]
0.041
  
Occupation (Farmer)
5.94 [1.65–21.39]
0.006
5.74 [1.55–21.25]
0.009
  
Individual IVM intake
0.91 [0.65–1.27]
0.566
0.92 [0.66–1.30]
0.646
  
Total nodule counts
0.93 [0.57–1.49]
0.751
0.91 [0.56–1.49]
0.709
  
Total nodule sites
1.43 [0.53–3.87]
0.484
1.52 [0.56–4.15]
0.411
  
ELR x10
1.69 [1.14–2.51]
0.009
    
Eosinophil [abs]
  
13.86 [2.07–92.90]
0.007
  
Model 1 included age, gender, years lived in an endemic area, distance to the nearest river, occupation, total nodule counts, total nodule sites, ENR; eosinophil-to-neutrophil ratio, EMR; eosinophil-to-monocyte ratio, EBR; eosinophil-to-basophil ratio, ELR; eosinophil-to-lymphocyte ratio

ENR, EMR, EBR and ELR significantly improve the conventional model for predicting microfilaridermia

To verify whether the addition of BCRs to a model containing conventional predictors could improve the classification of MF + and MF- onchocercomata participants, C-statistics were used (Table 7). The results show that eosinophil, ENR, EMR, EBR and ELR significantly improved the model by 4.7%, 4.2%, 4.3%, 3.3% and 3.6% respectively (Table 7). Combining all the BCRs significantly led to the improvement of the model by 4.0% (AUC = 81.8%, 95% CI (74.2–89.4), p < 0.0001) for predicting microfilaridermic participants. Strikingly, adding eosinophil to the combined BCRs showed the best discriminating ability of the model with an AUC of 82.9% (95% CI, 75.6–90.2, p < 0.0001).
Table 7
C-statistics for blood ratios to improve the predictability of microfilaridermia among study participants
Parameter
C-statistics
Estimate
95% CI
p-value
Model 1
0.778
0.692–0.864
< 0.0001
Model 1 + Eosinophil
0.825
0.752–0.899
< 0.0001
Model 1 + ENR
0.820
0.740–0.899
< 0.0001
Model 1 + EMR
0.821
0.745–0.897
< 0.0001
Model 1 + EBR
0.811
0.733–0.889
< 0.0001
Model 1 + ELR
0.814
0.739–0.889
< 0.0001
Model 1 + ENR + EMR + EBR + ELR
0.818
0.742–0.894
< 0.0001
Model 1 + Eosinophil + Combined ratios
0.829
0.756–0.902
< 0.0001
Model 1 was defined to include age, gender (male), years lived in an endemic area, distance to the nearest river, occupation (farmer), individual intake of MDA (ivermectin), total nodule counts and total nodule sites. ENR; eosinophil-to-neutrophil ratio, EMR; eosinophil-to-monocyte ratio, EBR; eosinophil-to-basophil ratio, ELR; eosinophil-to-lymphocyte ratio; combined ratios included ENR, EMR, EBR and ELR

Discussion

Attempts are being made to distinguish between onchocerciasis subgroups that have unique prognostic characteristics or display distinct responses to treatment due to the ongoing effects of CDTI [13, 16, 20]. Onchocerciasis causes chronic systemic inflammation even in patients with few pathologies. Various diagnostic markers have been used to detect systemic inflammation in patients including haemato-biochemical indices [30, 31]. Previous studies have shown that total WBC, neutrophil, eosinophil, basophil and monocytes play an important role and are used as indicators of an inflammatory response [30, 32]. In our study, we observed significantly higher total WBC, eosinophil and basophil counts in MF + participants implying an ongoing inflammatory reaction. Again, we observed that MF + participants had significantly higher eosinophils but less neutrophil counts compared to MF- participants corroborating previous findings [13, 20].
The enzyme gamma-glutamyl transferase (GGT) is mostly present in the liver and is important for maintaining intracellular glutathione levels [33, 34]. It is frequently employed as a marker for liver or biliary disorders [33]. Elevated GGT is linked to an increased risk of many chronic diseases, including cardiovascular disease, diabetes, metabolic syndrome and chronic infection [3537]. However, our study found that reduced GGT levels were significantly associated with MF + participants compared to MF- participants. The mechanism underlying this is unknown, and further research is needed to better understand the function of GGT in onchocerciasis subgroups and how it affects the inflammatory immune response.
Evaluation of glomerular filtration rate (GFR) is critical for the diagnosis and treatment of kidney diseases [38, 39]. The estimated GFR (eGFR), one of the several ways to measure GFR, is recommended for the initial evaluation of GFR [40]. Observational studies have shown that declining eGFR values are associated with an increased risk of kidney complications, cardiovascular diseases and mortality [39, 41]. Several parasitic infections have been associated with glomerular disease [4244]. Direct parasite destruction, immunological consequences, and systemic symptoms all play a role in the mechanism underlying parasite-induced kidney disease [45]. A study showed that onchocerciasis patients have a high prevalence of glomerular and tubular disturbances [46]. In this study, we observed a significantly lower eGFR among MF- participants compared to MF + participants. This could be due to immune complex-mediated damage caused by dead parasites among MF- participants [44, 45, 47].
Studies show that occupation, distance to the nearest river, age, compliance to the MDA programme, presence of nodules and gender are conventional predictors of onchocerciasis infections [13, 28, 48, 49]. We observed that farming was associated with an increased likelihood of microfilaridermia in our study before and after adjusting for covariables. Infectious bites from vectors may occur repeatedly during active farming periods, which typically are reported in endemic areas [50]. Kifle et al. showed that participants who lived < 2 km from the nearest river were more likely to have microfilaridermia compared to those who lived ≥ 2 km from the nearest river [51]. Our study observed that individuals who lived 1–2 km from the nearest river were less likely to have microfilaridermia compared to those who lived > 2 km away from the river. This could be due to the observed significantly higher intake of IVM among participants who lived nearer to the river than those far away in our study. Treatment coverage and compliance are highly effective at reducing the microfilariae burden at both community and individual levels [1, 52].
Centering on onchocerciasis infection, Tamarozzi et al., reported that inflammatory reaction to dead skin MF and MF in the eyes alongside the subsequent release of their bacterial endosymbiont Wolbachia was the basis of Onchocerca dermatitis and ocular keratitis immunopathology [18]. Microfilariae from Onchocerca dermatitis tissues have been reported to be surrounded by neutrophils, eosinophils or macrophages [53, 54]. Previous studies have emphasized the association between eosinophilia and the severity of onchocerciasis [5557]. Eosinophil infiltration into onchocercomata is triggered by MF and it has been shown that eosinophils actively attack MF [58, 59]. Evidence shows that live adult O. volvulus does not elicit eosinophilic invasion so long as they do not produce MF [58]. In chronically infected and untreated participants, eosinophil and macrophages infiltration cause permanent tissue damage [18]. Our study corroborates these hypotheses where we observed disproportionate abnormalities in eosinophil levels (51.4%) which were significantly associated with increased odds of microfilaridermia in MF + participants.
Focusing on basophil involvement in onchocerciasis infection, our findings corroborate the evidence that basophil numbers are increased in helminth infection [60, 61]. Basophils have been shown to release histamine and interleukin 4 (IL-4) in response to filarial nematodes where they function to amplify the ongoing type 2 immune response [62]. Furthermore, it has been shown that depletion of basophils results in a drastic reduction of eosinophils proliferation [62]. Labadah et al. reported a significantly lower basophil count with high eosinophil count in MF + participants compared to MF- participants [20]. In our study, MF + participants had significantly higher basophil compared to MF- participants. This may be because their participants were relatively younger than those observed in our study and a study showed that age significantly influences changes in neutrophil, basophil and eosinophil immunity [63].
Neutrophils are the major effector cells of early inflammatory infiltrate around damaged MF in the cornea and skin or attached to Wolbachia-containing adult worms [64, 65]. Their recruitment, activation and subsequent development of tissue pathology or systemic adverse events to a microfilaricidal drug depend on the endosymbiont Wolbachia [18]. Brattig et al. found that following doxycycline depletion of Wolbachia, the neutrophil infiltrates in onchocercomata were drastically reduced [64]. Although their role remains debatable, recent studies suggest that they may be involved in host protective immunity through Wolbachia-induced neutrophil extracellular trap formation (NET) [65, 66]. The function of this NETosis limits the dissemination and prevention of inflammatory damage induced by Wolbachia; provides an anti-parasitic response to limit MF production; and also limits the penetration of more damaging immune cells such as degranulating eosinophils [66]. Previously, we reported significantly higher levels of neutrophils among MF- participants compared to MF + participants [13]. A similar trend was observed in this study but was not statistically significant. This could be because of the homeostatic restoration of neutrophil activation after a limited period of IVM treatment [67, 68]. Neutrophil activation is observed during the adverse reaction following treatment with IVM and correlates with MF load, presence of Wolbachia DNA and proinflammatory cytokines [69]. Levels of neutrophils increase shortly after IVM and are reduced to baseline after 4–6 months of Wolbachia depletion [6870].
Different from previous studies, we evaluated the blood composite ratios (BCRs) of MF + and MF- participants based on reported interaction between eosinophil and other inflammatory cells in discriminating onchocerciasis subgroups [13, 20]. We observed significantly higher levels of ENR, EBR, EMR and ELR in the MF + participants compared to MF- participants. We also found that elevated ENR, EMR, EBR and ELR correlated positively with eosinophil but negatively with neutrophil in MF + participants. The clinical implications of these composite ratios have been reported particularly in inflammatory diseases, allergies and cancers. Higher ELR values were associated with worse survival results, according to Holub and Biete [26], who reported an AUROC of 0.61 for utilizing ELR to predict survival outcomes. Brescia et al., also observed that EBR was significantly higher in patients with inflammatory diseases [71]. These ratios have proved to be better prediction biomarkers than established biomarkers [72]. The increased ENR, EBR, EMR and ELR in this study suggest that they might serve as stable complementary biomarkers to eosinophils in predicting microfilariae in O. volvulus infection. ENR > 0.2265, EBR > 14.25 and ELR > 0.116 showed significantly higher specificity (> 80%) in diagnosing microfilaridermias. This is important to the current elimination goals of onchocerciasis, where ensuring a very high degree of specificity is paramount [73]. EMR is a stable biomarker [74] and proved to be very robust in discriminating between MF + and MF- participants in this study. At a level of > 0.395, EMR showed considerably higher specificity and sensitivity in detecting skin microfilariae. The reported specificity and sensitivity of these biomarkers corroborate reports on sensitivity and specificity by other researchers who explored these biomarkers [26, 74, 75]. Interestingly, we found that eosinophil alone had the highest AUROC value (73.8%) and presented much better accuracy than all the BCRs. The C-statistics analysis revealed that these markers should be considered as part of the conventional model of diagnosing microfilaridermia among onchocercomata patients and not as a standalone biomarker. In endemic areas with variable levels of medical resources, a routine complete blood count test is offered as part of the diagnosis. BCRs could be obtained from a simple calculation of absolute cell counts and may assist clinicians to judge whether patients will harbour microfilariae.
Our study is not without limitations. Even though according to the Ghana NTD Control Programme and other studies there may not be other filarial infections in the district [7678], we cannot exclusively reject the possibility of Onchocerciasis co-infection with other filarial diseases such LF and Mansonellosis in the participants recruited, but the chances are very low considering the site (Sefwi Akontombra district) where this study was carried out, which is the western North Region of Ghana. Also, as a retrospective study, it is burdened by all the associated limitations that accompany this type of data sampling method including an absence of data on potential confounders. Although the observed changes in blood ratios do not solely indicate microfilarial presence, they reflect the intricate interplay between eosinophils and the immune response. Therefore, their interpretation should be context specific. Notwithstanding, the results of our study should be considered as hypothesis generating as it has not been previously elucidated in this study population.
We do recommend that further confirmatory study in a sufficiently powered prospective analysis be done which considers the above-mentioned limitations.

Conclusion

To conclude, we observed a significantly higher total WBC, absolute eosinophil, absolute basophil, ENR, EBR, EMR and ELR levels in the MF + participants compared to MF- participants. We also found that ENR, EBR, EMR and ELR were significantly associated with increased odds of MF positivity in participants with onchocercomata. Combining BCRs with eosinophil significantly led to improvement in the conventional model for predicting microfilaridermia.

Acknowledgements

We thank the patients and Community Health Volunteers in the Sefwi Akontombra districts for their willingness to participate in this study. We also thank the Regional and District Health Directorates, including the Regional and District disease control officers, for their participation and assistance throughout the conduct of the study.

Declarations

Ethical approval of the study was obtained from the Committee on Human Research Publication and Ethics (CHRPE) of the School of Medicine and Dentistry of the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. Community leaders were consulted at the beginning of the study for their support and permission, and written approval was sought from the Western North Regional and the Sefwi Akontombra District Health Directorates. Informed consent was obtained from all participants and/or their legal guardians either by thumb printing or signing. This study was part of other larger studies titled: “The efficacy of rifampicin 35 mg/kg/d plus albendazole 400 mg/d given for 7 or 14 days against onchocerciasis– a randomized, controlled, parallel-group, open-label, phase II pilot trial” with registration number PACTR202009704006025, and “Prevalence assessment for onchocerciasis in some selected districts in Ghana”. The ethical approvals received for these studies were CHRPE/AP/359/20 and CHRPE/AP/492/20. The study was undertaken according to the principles and guidelines of the Helsinki Declaration of 1964, most recently amended in October 2013.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
7.
Zurück zum Zitat Katabarwa MN, Habomugisha P, Eyamba A, Byamukama E, Nwane P, Arinaitwe A et al. Community-directed interventions are practical and effective in low-resource communities: Experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004–2010. Int Health [Internet]. 2015 Mar 1 [cited 2021 Nov 11];8(2):116–23. https://academic.oup.com/inthealth/article/8/2/116/2458791. Katabarwa MN, Habomugisha P, Eyamba A, Byamukama E, Nwane P, Arinaitwe A et al. Community-directed interventions are practical and effective in low-resource communities: Experience of ivermectin treatment for onchocerciasis control in Cameroon and Uganda, 2004–2010. Int Health [Internet]. 2015 Mar 1 [cited 2021 Nov 11];8(2):116–23. https://​academic.​oup.​com/​inthealth/​article/​8/​2/​116/​2458791.
10.
Zurück zum Zitat Brattig NW. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes and Infection. Volume 6. Elsevier Masson; 2004. pp. 113–28. Brattig NW. Pathogenesis and host responses in human onchocerciasis: impact of Onchocerca filariae and Wolbachia endobacteria. Microbes and Infection. Volume 6. Elsevier Masson; 2004. pp. 113–28.
11.
Zurück zum Zitat Soboslay PT, Luder CGK, Hoffmann WH, Michaelis I, Helling G, Heuschkel C et al. Ivermectin-facilitated immunity in onchocerciasis: Activation of parasite- specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol [Internet]. 1994 [cited 2021 Nov 11];96(2):238–44. https://pubmed.ncbi.nlm.nih.gov/8187332/. Soboslay PT, Luder CGK, Hoffmann WH, Michaelis I, Helling G, Heuschkel C et al. Ivermectin-facilitated immunity in onchocerciasis: Activation of parasite- specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin Exp Immunol [Internet]. 1994 [cited 2021 Nov 11];96(2):238–44. https://​pubmed.​ncbi.​nlm.​nih.​gov/​8187332/​.
13.
Zurück zum Zitat Arndts K, Specht S, Debrah AY, Tamarozzi F, Klarmann Schulz U, Mand S et al. Immunoepidemiological profiling of Onchocerciasis patients reveals associations with Microfilaria loads and Ivermectin Intake on both individual and community levels. PLoS Negl Trop Dis. 2014;8(2). Arndts K, Specht S, Debrah AY, Tamarozzi F, Klarmann Schulz U, Mand S et al. Immunoepidemiological profiling of Onchocerciasis patients reveals associations with Microfilaria loads and Ivermectin Intake on both individual and community levels. PLoS Negl Trop Dis. 2014;8(2).
14.
Zurück zum Zitat Makepeace BL, Martin C, Turner JD, Specht S. Granulocytes in Helminth Infection - who is calling the shots? Curr Med Chem [Internet]. 2012 Mar 9 [cited 2021 Nov 12];19(10):1567–86. Available from: /pmc/articles/PMC3394172/. Makepeace BL, Martin C, Turner JD, Specht S. Granulocytes in Helminth Infection - who is calling the shots? Curr Med Chem [Internet]. 2012 Mar 9 [cited 2021 Nov 12];19(10):1567–86. Available from: /pmc/articles/PMC3394172/.
17.
Zurück zum Zitat Voehringer D. The role of basophils in helminth infection. Trends in Parasitology. Volume 25. Elsevier Current Trends; 2009. pp. 551–6. Voehringer D. The role of basophils in helminth infection. Trends in Parasitology. Volume 25. Elsevier Current Trends; 2009. pp. 551–6.
18.
Zurück zum Zitat Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ. Onchocerciasis: The role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev [Internet]. 2011 Jul [cited 2021 Nov 12];24(3):459–68. https://doi.org/10.1128/CMR.00057-10. Tamarozzi F, Halliday A, Gentil K, Hoerauf A, Pearlman E, Taylor MJ. Onchocerciasis: The role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment. Clin Microbiol Rev [Internet]. 2011 Jul [cited 2021 Nov 12];24(3):459–68. https://​doi.​org/​10.​1128/​CMR.​00057-10.
21.
Zurück zum Zitat Ramos-Lopez O, San-Cristobal R, Martinez-Urbistondo D, Micó V, Colmenarejo G, Villares-Fernandez P et al. Proinflammatory and hepatic features related to morbidity and fatal outcomes in covid-19 patients. J Clin Med [Internet]. 2021 Jul 15 [cited 2021 Nov 12];10(14):3112. https://www.mdpi.com/2077-0383/10/14/3112/htm. Ramos-Lopez O, San-Cristobal R, Martinez-Urbistondo D, Micó V, Colmenarejo G, Villares-Fernandez P et al. Proinflammatory and hepatic features related to morbidity and fatal outcomes in covid-19 patients. J Clin Med [Internet]. 2021 Jul 15 [cited 2021 Nov 12];10(14):3112. https://​www.​mdpi.​com/​2077-0383/​10/​14/​3112/​htm.
22.
Zurück zum Zitat Ciccullo A, Borghetti A, Zileri Dal Verme L, Tosoni A, Lombardi F, Garcovich M et al. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Int J Antimicrob Agents [Internet]. 2020 Aug 1 [cited 2021 Nov 12];56(2):106017. /pmc/articles/PMC7211594/. Ciccullo A, Borghetti A, Zileri Dal Verme L, Tosoni A, Lombardi F, Garcovich M et al. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Int J Antimicrob Agents [Internet]. 2020 Aug 1 [cited 2021 Nov 12];56(2):106017. /​pmc/​articles/​PMC7211594/​.
23.
Zurück zum Zitat Karauda T, Kornicki K, Jarri A, Antczak A, Miłkowska-Dymanowska J, Piotrowski WJ et al. Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD. Sci Reports 2021 111 [Internet]. 2021 Feb 26 [cited 2021 Nov 12];11(1):1–9. https://www.nature.com/articles/s41598-021-84439-8. Karauda T, Kornicki K, Jarri A, Antczak A, Miłkowska-Dymanowska J, Piotrowski WJ et al. Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD. Sci Reports 2021 111 [Internet]. 2021 Feb 26 [cited 2021 Nov 12];11(1):1–9. https://​www.​nature.​com/​articles/​s41598-021-84439-8.
24.
Zurück zum Zitat Cai H, Huang H, Yang C, Ren J, Wang J, Gao B et al. Eosinophil-to-neutrophil ratio predicts poor prognosis of Acute ischemic stroke patients treated with intravenous thrombolysis. Front Neurol. 2021;12. Cai H, Huang H, Yang C, Ren J, Wang J, Gao B et al. Eosinophil-to-neutrophil ratio predicts poor prognosis of Acute ischemic stroke patients treated with intravenous thrombolysis. Front Neurol. 2021;12.
27.
Zurück zum Zitat Ghana Statistical Service (GSS). Ghana 2021 Population and Housing Census: General Analytical Report - Sefwi Akontombra. Available: www.statsghana.gov.gh. Ghana Statistical Service (GSS). Ghana 2021 Population and Housing Census: General Analytical Report - Sefwi Akontombra. Available: www.statsghana.gov.gh.
29.
Zurück zum Zitat Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem [Internet]. 2007 Apr [cited 2022 Jun 22];53(4):766–72. https://pubmed.ncbi.nlm.nih.gov/17332152/. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem [Internet]. 2007 Apr [cited 2022 Jun 22];53(4):766–72. https://​pubmed.​ncbi.​nlm.​nih.​gov/​17332152/​.
31.
Zurück zum Zitat Ndzeshang BL, Mbiakop RT, Nchanji GT, Kien CA, Amambo GN, Abong RA et al. Clinical, haematological and biochemical profiling of podoconiosis lymphoedema patients prior to their involvement in a clinical trial in the Northwest Region of Cameroon. Trans R Soc Trop Med Hyg [Internet]. 2020 Dec 16 [cited 2022 Jun 22];114(12):954–61. https://academic.oup.com/trstmh/article/114/12/954/6015483. Ndzeshang BL, Mbiakop RT, Nchanji GT, Kien CA, Amambo GN, Abong RA et al. Clinical, haematological and biochemical profiling of podoconiosis lymphoedema patients prior to their involvement in a clinical trial in the Northwest Region of Cameroon. Trans R Soc Trop Med Hyg [Internet]. 2020 Dec 16 [cited 2022 Jun 22];114(12):954–61. https://​academic.​oup.​com/​trstmh/​article/​114/​12/​954/​6015483.
33.
Zurück zum Zitat Koenig G, Seneff S, Gamma-Glutamyltransferase. A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Vol. 2015, Disease Markers. Hindawi Limited; 2015. Koenig G, Seneff S, Gamma-Glutamyltransferase. A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Vol. 2015, Disease Markers. Hindawi Limited; 2015.
36.
Zurück zum Zitat Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F et al. Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol [Internet]. 2005 Dec 7 [cited 2022 Jun 22];11(45):7109–17. https://pubmed.ncbi.nlm.nih.gov/16437656/. Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F et al. Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress. World J Gastroenterol [Internet]. 2005 Dec 7 [cited 2022 Jun 22];11(45):7109–17. https://​pubmed.​ncbi.​nlm.​nih.​gov/​16437656/​.
38.
Zurück zum Zitat Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the New CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) Study. Am J Kidney Dis. 2010;55(4):648–59.CrossRefPubMedPubMedCentral Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the New CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) Study. Am J Kidney Dis. 2010;55(4):648–59.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: A meta-analysis. BMJ [Internet]. 2013 Jan 29 [cited 2022 Jul 15];346(7895). https://www.bmj.com/content/346/bmj.f324. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: A meta-analysis. BMJ [Internet]. 2013 Jan 29 [cited 2022 Jul 15];346(7895). https://​www.​bmj.​com/​content/​346/​bmj.​f324.
40.
41.
Zurück zum Zitat Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, Tzourio C et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly–the Three-City prospective cohort study. Nephrol Dial Transplant [Internet]. 2011 [cited 2022 Jul 15];26(10):3286–95. https://pubmed.ncbi.nlm.nih.gov/21677301/. Stengel B, Metzger M, Froissart M, Rainfray M, Berr C, Tzourio C et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly–the Three-City prospective cohort study. Nephrol Dial Transplant [Internet]. 2011 [cited 2022 Jul 15];26(10):3286–95. https://​pubmed.​ncbi.​nlm.​nih.​gov/​21677301/​.
42.
Zurück zum Zitat Batte A, Berrens Z, Murphy K, Mufumba I, Sarangam ML, Hawkes MT, et al. Malaria-associated acute kidney injury in African children: prevalence, pathophysiology, impact, and management challenges. Int J Nephrol Renovasc Dis. 2021;14:235–53.CrossRefPubMedPubMedCentral Batte A, Berrens Z, Murphy K, Mufumba I, Sarangam ML, Hawkes MT, et al. Malaria-associated acute kidney injury in African children: prevalence, pathophysiology, impact, and management challenges. Int J Nephrol Renovasc Dis. 2021;14:235–53.CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Faraj J, Mander J, Burnett JR, Prentice D. Filiarial chyluria with nephrotic-range proteinuria and associated hypoalbuminaemia and hypogammaglobulinaemia secondary to bilateral lymphorenal fistulae. BMJ Case Rep. 2017;2017:bcr2017221114.CrossRefPubMedPubMedCentral Faraj J, Mander J, Burnett JR, Prentice D. Filiarial chyluria with nephrotic-range proteinuria and associated hypoalbuminaemia and hypogammaglobulinaemia secondary to bilateral lymphorenal fistulae. BMJ Case Rep. 2017;2017:bcr2017221114.CrossRefPubMedPubMedCentral
48.
Zurück zum Zitat Njim T, Aminde LN. An appraisal of the neglected tropical diseases control program in Cameroon: the case of the national program against onchocerciasis. BMC Public Health. 2017;17(1). Njim T, Aminde LN. An appraisal of the neglected tropical diseases control program in Cameroon: the case of the national program against onchocerciasis. BMC Public Health. 2017;17(1).
49.
Zurück zum Zitat Dana D, Debalke S, Mekonnen Z, Kassahun W, Suleman S, Getahun K et al. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia. BMC Public Health. 2015;15(1). Dana D, Debalke S, Mekonnen Z, Kassahun W, Suleman S, Getahun K et al. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia. BMC Public Health. 2015;15(1).
51.
Zurück zum Zitat Kifle B, Woldemichael K, Nigatu M. Prevalence of Onchocerciasis and Associated Factors among adults aged ≥ 15 years in Semen Bench District, Bench Maji Zone, Southwest Ethiopia: community based cross-sectional study. Adv Public Heal. 2019;2019:1–9.CrossRef Kifle B, Woldemichael K, Nigatu M. Prevalence of Onchocerciasis and Associated Factors among adults aged ≥ 15 years in Semen Bench District, Bench Maji Zone, Southwest Ethiopia: community based cross-sectional study. Adv Public Heal. 2019;2019:1–9.CrossRef
54.
Zurück zum Zitat Darge K, Lucius R, Monson MH, Behrendsen J, Buttner DW. Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment. Trop Med Parasitol [Internet]. 1991 [cited 2022 Jan 7];42(4):361–7. https://europepmc.org/article/med/1796234. Darge K, Lucius R, Monson MH, Behrendsen J, Buttner DW. Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment. Trop Med Parasitol [Internet]. 1991 [cited 2022 Jan 7];42(4):361–7. https://​europepmc.​org/​article/​med/​1796234.
55.
56.
Zurück zum Zitat Wildenburg G, Darge K, Knab J, Tischendorf FW, Bonow I, Buttner DW. Lymph nodes of onchocerciasis patients after treatment with ivermectin: Reaction of eosinophil granulocytes and their cationic granule proteins. Trop Med Parasitol [Internet]. 1994 Jun 1 [cited 2021 Nov 12];45(2):87–96. https://europepmc.org/article/med/7939167. Wildenburg G, Darge K, Knab J, Tischendorf FW, Bonow I, Buttner DW. Lymph nodes of onchocerciasis patients after treatment with ivermectin: Reaction of eosinophil granulocytes and their cationic granule proteins. Trop Med Parasitol [Internet]. 1994 Jun 1 [cited 2021 Nov 12];45(2):87–96. https://​europepmc.​org/​article/​med/​7939167.
59.
Zurück zum Zitat Nfon CK, Makepeace BL, Njongmeta LM, Tanya VN, Bain O, Trees AJ. Eosinophils contribute to killing of adult Onchocerca ochengi within onchocercomata following elimination of Wolbachia. Microbes Infect. 2006;8(12–13):2698–705.CrossRefPubMed Nfon CK, Makepeace BL, Njongmeta LM, Tanya VN, Bain O, Trees AJ. Eosinophils contribute to killing of adult Onchocerca ochengi within onchocercomata following elimination of Wolbachia. Microbes Infect. 2006;8(12–13):2698–705.CrossRefPubMed
60.
Zurück zum Zitat Obata-Ninomiya K, Domeier PP, Ziegler SF. Basophils and eosinophils in Nematode infections. Frontiers in Immunology. Volume 11. Frontiers Media S.A.; 2020. p. 3014. Obata-Ninomiya K, Domeier PP, Ziegler SF. Basophils and eosinophils in Nematode infections. Frontiers in Immunology. Volume 11. Frontiers Media S.A.; 2020. p. 3014.
61.
Zurück zum Zitat Ohnmacht C, Voehringer D. Basophil effector function and homeostasis during helminth infection. Blood. 2009;113(12):2816–25.CrossRefPubMed Ohnmacht C, Voehringer D. Basophil effector function and homeostasis during helminth infection. Blood. 2009;113(12):2816–25.CrossRefPubMed
62.
Zurück zum Zitat Torrero MN, Hübner MP, Larson D, Karasuyama H, Mitre E. Basophils Amplify Type 2 Immune Responses, but Do Not Serve a Protective Role, during Chronic Infection of Mice with the Filarial Nematode Litomosoides sigmodontis. J Immunol [Internet]. 2010 Dec 15 [cited 2022 Jan 5];185(12):7426–34. https://pubmed.ncbi.nlm.nih.gov/21057084/. Torrero MN, Hübner MP, Larson D, Karasuyama H, Mitre E. Basophils Amplify Type 2 Immune Responses, but Do Not Serve a Protective Role, during Chronic Infection of Mice with the Filarial Nematode Litomosoides sigmodontis. J Immunol [Internet]. 2010 Dec 15 [cited 2022 Jan 5];185(12):7426–34. https://​pubmed.​ncbi.​nlm.​nih.​gov/​21057084/​.
66.
Zurück zum Zitat Tamarozzi F, Turner JD, Pionnier N, Midgley A, Guimaraes AF, Johnston KL et al. Wolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis. Sci Rep [Internet]. 2016 Oct 18 [cited 2022 Jan 5];6(1):1–13. https://www.nature.com/articles/srep35559. Tamarozzi F, Turner JD, Pionnier N, Midgley A, Guimaraes AF, Johnston KL et al. Wolbachia endosymbionts induce neutrophil extracellular trap formation in human onchocerciasis. Sci Rep [Internet]. 2016 Oct 18 [cited 2022 Jan 5];6(1):1–13. https://​www.​nature.​com/​articles/​srep35559.
68.
Zurück zum Zitat Francis H, Awadzi K, Ottesen EA. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: Clinical severity as a function of infection intensity. Am J Trop Med Hyg [Internet]. 1985 [cited 2022 Jul 19];34(3):529–36. https://europepmc.org/article/med/4003668. Francis H, Awadzi K, Ottesen EA. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: Clinical severity as a function of infection intensity. Am J Trop Med Hyg [Internet]. 1985 [cited 2022 Jul 19];34(3):529–36. https://​europepmc.​org/​article/​med/​4003668.
71.
Zurück zum Zitat Brescia G, Barion U, Zanotti C, Cinetto F, Giacomelli L, Martini A et al. Blood eosinophil-to-basophil ratio in patients with sinonasal polyps: Does it have a clinical role? Ann Allergy Asthma Immunol [Internet]. 2017 Sep 1 [cited 2022 Jan 6];119(3):223–6. https://pubmed.ncbi.nlm.nih.gov/28743424/. Brescia G, Barion U, Zanotti C, Cinetto F, Giacomelli L, Martini A et al. Blood eosinophil-to-basophil ratio in patients with sinonasal polyps: Does it have a clinical role? Ann Allergy Asthma Immunol [Internet]. 2017 Sep 1 [cited 2022 Jan 6];119(3):223–6. https://​pubmed.​ncbi.​nlm.​nih.​gov/​28743424/​.
73.
Zurück zum Zitat Unnasch TR, Golden A, Cama V, Cantey PT. Diagnostics for onchocerciasis in the era of elimination [Internet]. Vol. 10, International Health. Oxford University Press; 2018 [cited 2022 Jul 19]. pp. i20–6. /pmc/articles/PMC5881263/. Unnasch TR, Golden A, Cama V, Cantey PT. Diagnostics for onchocerciasis in the era of elimination [Internet]. Vol. 10, International Health. Oxford University Press; 2018 [cited 2022 Jul 19]. pp. i20–6. /​pmc/​articles/​PMC5881263/​.
76.
Zurück zum Zitat Adu Mensah D, Debrah LB, Gyamfi PA, Rahamani AA, Opoku VS, Boateng J, Obeng P, Osei-Mensah J, Kroidl I, Klarmann-Schulz U, Hoerauf A, Debrah AY. Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana. PLoS Negl Trop Dis. 2022;16(8):e0010129. https://doi.org/10.1371/journal.pntd.0010129 PMID: 35926012. Adu Mensah D, Debrah LB, Gyamfi PA, Rahamani AA, Opoku VS, Boateng J, Obeng P, Osei-Mensah J, Kroidl I, Klarmann-Schulz U, Hoerauf A, Debrah AY. Occurrence of Lymphatic Filariasis infection after 15 years of mass drug administration in two hotspot districts in the Upper East Region of Ghana. PLoS Negl Trop Dis. 2022;16(8):e0010129. https://​doi.​org/​10.​1371/​journal.​pntd.​0010129 PMID: 35926012.
77.
Zurück zum Zitat Phillips RO, Frimpong M, Sarfo FS, Kretschmer B, Beissner M, Debrah A, Ampem-Amoako Y, Abass KM, Thompson W, Duah MS, Abotsi J. Infection with Mansonella perstans nematodes in Buruli ulcer patients, Ghana. Emerg Infect Dis. 2014;20(6):1000.CrossRefPubMedPubMedCentral Phillips RO, Frimpong M, Sarfo FS, Kretschmer B, Beissner M, Debrah A, Ampem-Amoako Y, Abass KM, Thompson W, Duah MS, Abotsi J. Infection with Mansonella perstans nematodes in Buruli ulcer patients, Ghana. Emerg Infect Dis. 2014;20(6):1000.CrossRefPubMedPubMedCentral
78.
Zurück zum Zitat Debrah LB, Nausch N, Opoku VS, Owusu W, Mubarik Y, Berko DA, Wanji S, Layland LE, Hoerauf A, Jacobsen M, Debrah AY. Epidemiology of Mansonella perstans in the middle belt of Ghana. Parasites Vectors. 2017;10(1):1–8.CrossRef Debrah LB, Nausch N, Opoku VS, Owusu W, Mubarik Y, Berko DA, Wanji S, Layland LE, Hoerauf A, Jacobsen M, Debrah AY. Epidemiology of Mansonella perstans in the middle belt of Ghana. Parasites Vectors. 2017;10(1):1–8.CrossRef
Metadaten
Titel
Association of haemato-biochemical indices and blood composite ratios with microfilaridermia in Onchocerciasis patients
verfasst von
Linda Batsa Debrah
Charles Gyasi
Monica Ahiadorme
Abu Abudu Rahamani
Vera Serwaa Opoku
Prince Obeng
Jubin Osei-Mensah
Michael Agyemang Obeng
Derrick Adu Mensah
Alexander Yaw Debrah
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2024
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-024-09278-0

Weitere Artikel der Ausgabe 1/2024

BMC Infectious Diseases 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.